AN2 Therapeutics Inc. (ANTX)
1.12
-0.02 (-1.75%)
At close: Mar 03, 2025, 11:50 AM
AN2 Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Hold
Price Target
5
Upside
346.71
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Roy Buchanan (0)
| Citizens Capital Mar... | Buy | Reiterates | 5 5 | Feb 25, 2025 |
Roy Buchanan (0)
| JMP Securities | Buy | Reiterates | 5 5 | Feb 3, 2025 |
Roy Buchanan (0)
| JMP Securities | Buy | Reiterates | 5 5 | Nov 19, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.